These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9321736)

  • 1. Association of tachycardia with morbidity and mortality: pathophysiological considerations.
    Palatini P; Julius S
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S19-27. PubMed ID: 9321736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated heart rate as a predictor of increased cardiovascular morbidity.
    Palatini P
    J Hypertens Suppl; 1999 Aug; 17(3):S3-10. PubMed ID: 10489092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiological determinants and risk correlations of elevated heart rate.
    Palatini P; Julius S
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):3S-8S. PubMed ID: 10077413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs.
    Palatini P
    Drugs; 1999 May; 57(5):713-24. PubMed ID: 10353296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachycardia: an important determinant of coronary risk in hypertension.
    Julius S; Palatini P; Nesbitt SD
    J Hypertens Suppl; 1998 Jan; 16(1):S9-15. PubMed ID: 9534091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
    Julius S
    Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of heart rate as a risk factor in hypertension.
    Palatini P; Julius S
    Curr Hypertens Rep; 1999 Jun; 1(3):219-24. PubMed ID: 10981069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical consequences of the autonomic imbalance in hypertension and congestive heart failure.
    Julius S; Nesbitt S
    Scand Cardiovasc J Suppl; 1998; 47():23-30. PubMed ID: 9540130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity.
    Valensi P; Doaré L; Perret G; Germack R; Pariès J; Mesangeau D
    Obes Res; 2003 Jan; 11(1):54-64. PubMed ID: 12529486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing role of the autonomic nervous system in human hypertension.
    Julius S
    J Hypertens Suppl; 1990 Dec; 8(7):S59-65. PubMed ID: 2095397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heart rate: a cardiovascular risk factor that can no longer be ignored].
    Palatini P
    G Ital Cardiol (Rome); 2006 Feb; 7(2):119-28. PubMed ID: 16532723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension--heart rate and cardiovascular risk].
    Bénétos A
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1371-6. PubMed ID: 11190282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome.
    Bonyhay I; Freeman R
    Circulation; 2004 Nov; 110(20):3193-8. PubMed ID: 15533861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.